Investor opportunities

Limmedx is currently raising capital to bring its device for treating acute gastric variceal bleeding to market in the EU and to support its clinical development in the US. This represents a unique opportunity for investors, as Limmedx anticipates gaining a significant market share within the first year of launch.

Due to its ease of use, Limmedx is aiming for its device to become market leader by 2018.  Revenue will initially be secured from the EU market, before expanding into the US market.

Limmedx will sustain growth through technical improvements, market extensions and the design and development of further novel devices.

Areas of research:

  1. Devices to treat acute gastric variceal bleeding.

  2. Other causes of acute gastrointestinal bleeding amenable to
       polymer treatment.

  3. Bariatric approaches for moderate obesity.

  4. Endoscopic therapies for gastrointestinal fistulae.